A new law will go into effect in Louisiana on Oct. 1 that will classify two drugs—mifepristone and misoprostol, which are commonly used for abortions, postpartum hemorrhaging, and miscarriage management—as “controlled dangerous substances.” The change is worrying doctors who say the repercussions could be life-threatening for some.

The New Orleans City Council is directing the city’s health department to investigate the impact of a new law about drugs used in pregnancy and abortion.

A new Louisiana law in effect Oct. 1 will re-classify misoprostol as a dangerous controlled substance. It's used in medication abortions, but also for postpartum hemorrhage and other obstetric issues.

A new law will go into effect in Louisiana on Oct. 1 that will classify two drugs—mifepristone and misoprostol, which are commonly used for abortions, postpartum hemorrhaging, and miscarriage management—as “controlled dangerous substances.

With a new Louisiana law reclassifying two drugs that can be used to induce abortions as controlled substances set to take effect Oct. 1, doctors are practicing how quickly they can get their hands on the lifesaving medication while also abiding by new state guidance,